Yükleniyor…
kapsadığımız 84 şirket, bunlardan 78 tanesi notlu
Buradaki her şirket aynı beş büyüme ve nakit üretimi kontrolünden geçirildi. Bu, sektörü bugün bildirdiği hâliyle anlatır — hangisinin alınacağını değil.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | A | $45,7B | $39,19 | 65,32 | $17,3B | %4,1 |
| HLN | Haleon plc | B+ | $41,4B | $9,26 | 18,87 | $14,6B | %15,1 |
| TAK | Takeda Pharmaceutical Company Limited | B | $30,3B | $18,86 | 44,01 | $28,7B | -%3,4 |
| ZTS | Zoetis Inc. | A+ | $29,4B | $71,05 | 11,71 | $9,5B | %27,5 |
| VTRS | VIATRIS INC. | C | $20,5B | $17,83 | — | $14,7B | -%23,9 |
| UTHR | United Therapeutics Corporation | B+ | $20,4B | $475,45 | 17,02 | $3,2B | %41,6 |
| NBIX | NEUROCRINE BIOSCIENCES INC | A+ | $14,1B | $138,40 | 20,29 | $3,4B | %20,9 |
| ELAN | Elanco Animal Health Incorporated | A | $11,1B | $22,31 | — | $5B | -%4,0 |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B+ | $10,2B | $12,25 | 17,35 | $3,5B | %12,8 |
| ALKS | Alkermes plc. | B | $6,9B | $40,85 | 107,50 | $1,7B | %4,0 |
| HIMS | HIMS & HERS HEALTH, INC. | A- | $6,8B | $29,42 | — | $2,6B | -%5,5 |
| LNTH | Lantheus Holdings, Inc. | A+ | $6,5B | $99,74 | 24,15 | $1,6B | %17,7 |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | C | $6,3B | $19,77 | 40,35 | $3,1B | %5,0 |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | $6,2B | $75,08 | 82,51 | $754M | %9,7 |
| LQDA | LIQUIDIA CORPORATION | A+ | $6,1B | $68,43 | 49,23 | $450,9M | %30,7 |
| INDV | Indivior Pharmaceuticals, Inc. | D | $4,2B | $35,82 | 12,84 | $1,3B | %26,7 |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | $3,3B | $29,49 | — | $0,00 | — |
| RGC | Regencell Bioscience Holdings Limited | notsuz | $3,1B | $6,17 | — | — | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | C- | $2,5B | $42,66 | — | $830,4M | -%13,2 |
| HCM | HutchMED (China) LIMITED | D | $2,4B | $13,94 | 26,81 | $549,1M | %3,3 |
| TRLV | TRULIEVE CANNABIS CORP. | D | $2,4B | $12,21 | — | $1,1B | -%41,8 |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | $2,2B | $46,61 | 13,06 | $1,1B | %15,6 |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | A | $2,2B | $8,59 | — | $940,6M | -%40,9 |
| PRGO | Perrigo Company plc | F- | $2,1B | $15,42 | — | $4,1B | -%41,9 |
| BHC | Bausch Health Companies Inc. | A | $2,1B | $5,69 | — | $10,9B | -%10,1 |
| ALVO | ALVOTECH | B | $1,8B | $5,75 | 57,50 | $586,3M | %4,8 |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | $1,7B | $9,10 | — | $335,4M | -%5,1 |
| ETON | Eton Pharmaceuticals, Inc. | A+ | $1,6B | $57,68 | — | $105,6M | %12,0 |
| ANIP | ANI PHARMACEUTICALS, INC | A+ | $1,6B | $74,00 | 15,98 | $978,4M | %11,1 |
| PAHC | Phibro Animal Health Corporation | B | $1,4B | $34,45 | 14,12 | $1,5B | %6,6 |
| HROW | Harrow, Inc. | B- | $1,2B | $33,07 | — | $275,6M | -%13,5 |
| CRON | CRONOS GROUP INC. | A | $1,2B | $3,34 | 16,70 | $179,1M | %39,1 |
| AMPH | Amphastar Pharmaceuticals, Inc. | A+ | $1,1B | $26,13 | 15,46 | $730M | %10,8 |
| PCRX | PACIRA BIOSCIENCES, INC. | A | $1B | $25,12 | 71,77 | $746,2M | %2,0 |
| COLL | Collegium Pharmaceutical, Inc. | A+ | $733,5M | $22,53 | 18,17 | $808,2M | %5,9 |
| IRWD | IRONWOOD PHARMACEUTICALS, INC. | C+ | $682,4M | $4,13 | 5,36 | $389,3M | %33,4 |
| AQST | Aquestive Therapeutics, Inc. | C | $587,4M | $4,68 | — | $54,1M | -%144,6 |
| TLRY | Tilray Brands, Inc. | C- | $562,5M | $4,13 | — | $915,5M | -%13,3 |
| GLAS | Glass House Brands Inc. | D- | $557,2M | $6,80 | — | $152,9M | -%33,7 |
| EOLS | EVOLUS, INC. | B | $526,4M | $7,97 | — | $316,5M | -%10,8 |
| KMDA | KAMADA LTD | C | $503M | $8,72 | 22,95 | $191,8M | %11,6 |
| TKNO | ALPHA TEKNOVA, INC. | B- | $500,9M | $9,33 | — | $43,7M | -%38,4 |
| CGC | Canopy Growth Corp | D- | $398,3M | $0,94 | — | $207,3M | -%79,2 |
| EBS | EMERGENT BIOSOLUTIONS INC. | C | $348,1M | $6,79 | — | $770,2M | -%23,0 |
| BIOA | BIOAGE LABS, INC. | D- | $323,6M | $7,05 | — | $10,4M | -%912,3 |
| INCR | INTERCURE LTD. | C- | $284,9M | $5,21 | — | $88,2M | -%13,2 |
| EVO | Evotec SE | D- | $277,3M | $1,56 | — | $897M | -%13,1 |
| ANIK | Anika Therapeutics, Inc. | B- | $272,6M | $20,37 | — | $120,7M | -%3,1 |
| AKBA | AKEBIA THERAPEUTICS, INC. | C | $248,3M | $0,90 | — | $219,1M | -%13,5 |
| SIGA | Siga Technologies INC | F- | $247,9M | $3,45 | — | $53,7M | -%5,2 |
| ACB | AURORA CANNABIS INC | D | $230,6M | $4,10 | 145,20 | $226,3M | -%42,4 |
| ORGO | ORGANOGENESIS HOLDINGS INC. | B- | $181,4M | $1,41 | — | $457,5M | -%18,4 |
| CRDL | Cardiol Therapeutics Inc. | notsuz | $171,4M | $1,71 | — | — | — |
| DERM | Journey Medical Corp | C- | $168,2M | $6,14 | — | $68,2M | -%9,0 |
| ADCT | ADC Therapeutics SA | D | $162,1M | $1,27 | — | $79,6M | -%121,8 |
| LFCR | LIFECORE BIOMEDICAL, INC. | D | $159M | $4,20 | — | $128,9M | -%30,0 |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | $114M | $7,61 | — | $39,9M | -%27,4 |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | $104,8M | $1,10 | — | $183M | -%9,6 |
| CTOR | Citius Oncology, Inc. | notsuz | $97,6M | $1,05 | — | — | — |
| ZYBT | Zhengye Biotechnology Holding Limited | D | $61,8M | $1,31 | 35,03 | $17,3M | -%60,0 |
| SCYX | SCYNEXIS, Inc. | F- | $43,7M | $4,39 | 15,14 | $19,2M | -%53,3 |
| IMCC | IM Cannabis Corp. | C | $36,4M | $2,84 | — | $32,3M | -%39,1 |
| RMTI | ROCKWELL MEDICAL, INC. | B- | $33,7M | $8,37 | — | $69,4M | -%7,3 |
| CPHI | CHINA PHARMA HOLDINGS, INC. | C- | $32,3M | $0,75 | — | $3,9M | -%114,3 |
| BGM | BGM Group Ltd | F- | $27,2M | $0,24 | — | $37,9M | -%52,6 |
| AYTU | AYTU BIOPHARMA, INC | C | $24,8M | $2,28 | — | $57,6M | -%24,8 |
| TXMD | TherapeuticsMD, Inc. | F- | $23,7M | $2,05 | — | $3,3M | -%6,6 |
| RDHL | REDHILL BIOPHARMA LTD. | F- | $22,5M | $0,50 | — | $286K | -%150,0 |
| BFRI | Biofrontera Inc. | B- | $17,5M | $1,18 | — | $46,2M | -%13,8 |
| TLPH | TALPHERA, INC. | C- | $16,8M | $1,18 | — | $1K | -%1.507.600,0 |
| CABR | CARING BRANDS, INC. | F- | $12,8M | $1,24 | — | $4,2K | -%183.255,2 |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | notsuz | $10,9M | $7,25 | — | — | — |
| INM | INMED PHARMACEUTICALS INC. | D- | $7,6M | $1,38 | — | $4,5M | -%278,7 |
| SNOA | SONOMA PHARMACEUTICALS, INC. | B- | $6,1M | $1,27 | — | $21,9M | -%10,3 |
| GELS | Gelteq Limited | D- | $5,2M | $0,55 | — | $116,3K | -%4.011,9 |
| SBFM | Sunshine Biopharma Inc. | C- | $3,3M | $0,84 | — | $35,3M | -%16,5 |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | notsuz | $3M | $4,01 | — | — | — |
| UPC | Universe Pharmaceuticals INC | D- | $2,7M | $4,75 | — | $17,9B | -%20,6 |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | $2,5M | $2,57 | — | $1,1M | -%545,2 |
| YCBD | cbdMD, Inc. | D- | $1,9M | $0,47 | — | $20,9M | -%13,8 |
| IXHL | Incannex Healthcare Inc. | F- | $1,7M | $3,32 | — | $0,00 | — |
| PRFX | PRF Technologies Ltd. | B- | $811,3K | $0,98 | — | $17K | -%29.541,2 |
| AKAN | AKANDA CORP. | F | $210,3K | $3,05 | 0,24 | $258,1K | -%17.690,2 |
| OPTH | Optimi Health Corp. | notsuz | — | $4,82 | — | — | — |
Temeller SEC belgelerinden, fiyatlar son piyasa verisi taramasından. İstediğiniz sütuna göre sıralayın; rakamı olmayan şirketler her iki yönde de sona düşer.
Piyasa değerine göre büyükten küçüğe sıralı; yeniden sıralamak için herhangi bir sütuna tıklayın. Rakamı olmayan şirketler her iki yönde de sona düşer, çünkü eksik bir F/K ucuzluk değil zarar demektir. Buradaki hiçbir şey bir öneri değildir.